Document is current

Any future updates will be listed below

Oral FPR2/ALX modulators tune myeloid cell activity to ameliorate mucosal inflammation in inflammatory bowel disease

Crossref DOI link: https://doi.org/10.1038/s41401-025-01525-7

Published Online: 2025-03-11

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark